CBD 101:
Innovative Extraction Technique Yields Elevated Cannabinoid Levels with Enhanced Stability
Cannabis extraction methods have long been an essential aspect of unlocking the plant's therapeutic potential. With advancements in technology and understanding, new methods emerge, each offering unique benefits and challenges. Among these innovators stands Peter Vermeul, whose accidental discovery has sparked curiosity and raised eyebrows in the cannabis community.
Vermeul's journey started more than four years ago when he developed his first CBG varieties. What followed were astonishing laboratory results that defied conventional wisdom. An extraction process that should have yielded a ratio of (at most) 10 of plant to extract instead yielded a substantially higher concentration of cannabinoids. For example, a CBG plant with 12% CBGa and 0.5% CBDa is converted into an extract with 15% CBGa and 17% CBDa. Such an anomaly led Vermeul to delve deeper into the extraction process, leading to a revelation that challenged existing norms.
Remarkable CBDa Stability Even After Many Years
In Vermeul's Words
Vermeul's findings have attracted the attention of prominent figures in the field, including specialists like Dr. Raphael Mechoulam (R.I.P) from Israel and Vangelis Mitsis from Greece, while Vermeul shared his results with them. To date, no one has been able to fully explain the mechanisms behind Vermeul's unique extraction process.
Conclusion
Highlighting how extraction methods might alter the chemical profile of a given chemovar opens doors to understanding the nuanced effects of different cannabis formulations on therapeutic outcomes. It is conceivable that variations in extraction techniques could lead to differential concentrations of cannabinoids, terpenes, and other phytochemicals present in the plant. For instance, employing methods that prioritize the preservation of delicate compounds such as CBDa or specific terpenes could result in formulations with enhanced therapeutic properties tailored to address specific medical conditions. By selectively extracting and formulating cannabinoids and terpenes, it is plausible that these refined formulations could offer heightened efficacy in targeted treatment regimens, offering patients more precise and effective therapeutic interventions.